Endothelium derived nitric oxide is a potent vasodilator and anti- inflammatory autocoid that has profound effects on basic cellular functions including gene expression, cell migration, proliferation and differentiation. Previous studies have demonstrated that compartmentalization of endothelial nitric oxide synthase (eNOS) is negatively regulated by a direct interaction with a coat protein of endothelial caveolae, caveolin- I (CAV- 1) and is activated by a direct interaction with a newly identified NOS regulatory protein, heat shock protein-90 (Hsp 90). With this background in mind, it is hypothesized that endothelium-derived NO production is regulated by dynamic protein- protein interactions between eNOS, CAV- 1 and Hsp9O and such interactions are responsible for the compartmentalization of eNOS activation. To examine the regulation of these important interactions the following specific aims are proposed.
Aim 1 will elucidate the importance of eNOS/CAV- 1 interactions in cellular trafficking and activation eNOS.
Aim 2 will characterize the molecular interactions of eNOS with Hsp 90 and elucidate the signaling pathways required for stimulus dependent association of the two proteins.
Aim 3 will examine the interrelationships between eNOS, CAV- 1 and Hsp9O. In all of the above AIMS, molecular and cell biological approaches to elucidate eNOS trafficking, fatty acylation and protein-protein interactions will be combined with functional analysis of eNOS activity and NO release. Collectively this work will facilitate our understanding of the molecular machinery required for eNOS activation in EC. The long-term goal is to utilize this information to gain a better understanding of the mechanisms of endothelial dysfunction, a common manifestation of a variety of cardiovascular disorders

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061371-05
Application #
6625280
Study Section
Pathology A Study Section (PTHA)
Program Officer
Goldman, Stephen
Project Start
1998-12-01
Project End
2003-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
5
Fiscal Year
2003
Total Cost
$431,864
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Luciano, Amelia K; Zhou, Wenping; Santana, Jeans M et al. (2018) CLOCK phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues. J Biol Chem 293:9126-9136
Kuo, Andrew; Lee, Monica Y; Yang, Kui et al. (2018) Caveolin-1 regulates lipid droplet metabolism in endothelial cells via autocrine prostacyclin-stimulated, cAMP-mediated lipolysis. J Biol Chem 293:973-983
Luciano, Amelia K; Santana, Jeans M; Velazquez, Heino et al. (2017) Akt1 Controls the Timing and Amplitude of Vascular Circadian Gene Expression. J Biol Rhythms 32:212-221
Grabi?ska, Kariona A; Edani, Ban H; Park, Eon Joo et al. (2017) A conserved C-terminal RXG motif in the NgBR subunit of cis-prenyltransferase is critical for prenyltransferase activity. J Biol Chem 292:17351-17361
Hoffmann, Reuben; Grabi?ska, Kariona; Guan, Ziqiang et al. (2017) Long-Chain Polyprenols Promote Spore Wall Formation in Saccharomyces cerevisiae. Genetics 207:1371-1386
Kuo, Andrew; Lee, Monica Y; Sessa, William C (2017) Lipid Droplet Biogenesis and Function in the Endothelium. Circ Res 120:1289-1297
Kraehling, Jan R; Sessa, William C (2017) Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease. Circ Res 120:1174-1182
Kraehling, Jan R; Hao, Zhengrong; Lee, Monica Y et al. (2016) Uncoupling Caveolae From Intracellular Signaling In Vivo. Circ Res 118:48-55
Ulrich, Victoria; Rotllan, Noemi; Araldi, Elisa et al. (2016) Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice. EMBO Mol Med 8:643-53
Grabi?ska, Kariona A; Park, Eon Joo; Sessa, William C (2016) cis-Prenyltransferase: New Insights into Protein Glycosylation, Rubber Synthesis, and Human Diseases. J Biol Chem 291:18582-90

Showing the most recent 10 out of 110 publications